天目药业：关于全资子公司收到药品再注册批准通知书的公告

Core Viewpoint - Tianmu Pharmaceutical announced that its wholly-owned subsidiary, Huangshan Tianmu Pharmaceutical Co., Ltd., has received the "Drug Re-registration Approval Notice" issued by the Anhui Provincial Drug Administration [2] Group 1 - The approval is a significant regulatory milestone for the company, indicating compliance with local drug regulations [2] - This re-registration may enhance the company's market position and product availability in the region [2] - The announcement reflects the company's ongoing commitment to maintaining regulatory standards and expanding its operational capabilities [2]